Switch Therapeutics Funding: $52M Raised, Series A (2023)
Switch Therapeutics is based in South San Francisco. It has raised $52M in total funding. Latest round: Series A.
Switch Therapeutics funding overview
Switch Therapeutics is based in South San Francisco. Switch Therapeutics has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Switch Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Insight Partners, UCB Ventures, Upfront Ventures, BOLD Capital Partners, Eli Lilly and Company, Ono Venture Investment and 4 others. 10 distinct backers are named across the disclosed rounds.
Switch Therapeutics at a glance
Total raised
$52M
Latest round
Series A
Latest round date
March 2023
Headquarters
South San Francisco
Notable investors
Insight Partners, UCB Ventures, Upfront Ventures, BOLD Capital Partners, Eli Lilly and Company, Ono Venture Investment, Digitalis Ventures, Dolby Family Ventures
Frequently asked about Switch Therapeutics funding
How much has Switch Therapeutics raised?
Switch Therapeutics has raised $52M in total disclosed funding across the rounds on record.
Who has invested in Switch Therapeutics?
Insight Partners, UCB Ventures, Upfront Ventures, BOLD Capital Partners, Eli Lilly and Company, Ono Venture Investment are named among the investors backing Switch Therapeutics.
What was the latest Switch Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Switch Therapeutics based?
Switch Therapeutics is based in South San Francisco.
When did Switch Therapeutics last raise?
The last disclosed Switch Therapeutics round closed in March 2023 at Series A.
Switch Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.
